Calypte's HIV-1 Urine Test Approved for Use in People's Republic of China
(ALAMEDA, CA) Calypte Biomedical Corporation has announced that the State Drug Administration of the People's Republic of China (PRC) has approved its HIV-1 antibody urine test. According to the Joint Nations Programme on HIV/AIDS, half a million Chinese citizens are currently infected with the HIV virus. Left unchecked, officials of the Chinese National Center for AIDS Prevention and Control (NCAIDS) estimate that the total number of HIV infections in China could reach 10 million before 2010. Earlier this year, Calypte announced that it had partnered with NCAIDS through Beijing HuaAi Science and Technology Development Co. Ltd. to distribute the HIV-1 urine test within the PRC. For more information visit www.calypte.com.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
